147.40
-6.00
(-3.91%)
As of 5:00:29 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in SEK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 5 | 5 |
| Avg. Estimate | 0.91 | 1.07 | 4.86 | 5.74 |
| Low Estimate | 0.8 | 0.9 | 3.7 | 4.6 |
| High Estimate | 0.98 | 1.23 | 7.09 | 7.81 |
| Year Ago EPS | 0.85 | 1.06 | 3.78 | 4.86 |
Revenue Estimate
| Currency in SEK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 5 |
| Avg. Estimate | 887.73M | 967.58M | 3.79B | 4.14B |
| Low Estimate | 859M | 937M | 3.68B | 4.01B |
| High Estimate | 901M | 998M | 3.86B | 4.22B |
| Year Ago Sales | 841M | 941M | 3.61B | 3.79B |
| Sales Growth (year/est) | 5.56% | 2.82% | 4.94% | 9.38% |
Earnings History
| Currency in SEK | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1 | 1 | 1.05 | 1.1 |
| EPS Actual | 0.85 | 1.06 | 0.85 | 1.02 |
| Difference | -0.15 | 0.06 | -0.2 | -0.08 |
| Surprise % | -15.00% | 6.00% | -19.05% | -7.27% |
EPS Trend
| Currency in SEK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.91 | 1.07 | 4.86 | 5.74 |
| 7 Days Ago | 0.95 | 1.23 | 4.92 | 5.78 |
| 30 Days Ago | 0.95 | 1.23 | 5.29 | 6.03 |
| 60 Days Ago | 0 | 0 | 4.58 | 6.03 |
| 90 Days Ago | 0 | 0 | 5.69 | 6.46 |
EPS Revisions
| Currency in SEK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | 1 | 2 |
| Down Last 30 Days | -- | -- | 1 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VITR.ST | 7.06% | 0.47% | 28.57% | 18.02% |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Related Tickers
CEVI.ST CellaVision AB (publ)
149.80
-4.95%
XVIVO.ST Xvivo Perfusion AB (publ)
263.00
-4.29%
EMBLA.CO Embla Medical hf
25.16
-6.00%
REG1V.HE Revenio Group Oyj
22.65
-3.82%
ABL.HA Abbott Laboratories
109.48
-5.18%
688139.SS Qingdao Haier Biomedical Co.,Ltd
32.39
+1.16%
BACTI-B.ST Bactiguard Holding AB (publ)
31.30
+5.39%
GME.DE Geratherm Medical AG
3.2000
-4.48%
CRBX.ST Carbiotix AB
8.70
-5.02%
NEOLA.ST Neola Medical AB (publ)
2.6600
-2.56%